Extracellular vesicles (EVs), including exosomes, microvesicles, and oncosomes, are nano-
sized particles enclosed by a lipid bilayer. EVs are released by virtually all eukaryotic cells …

Abstract Alzheimer's disease (AD), manifested by memory loss and a decline in cognitive
functions, is the most prevalent neurodegenerative disease accounting for 60–80% of …

Extracellular vesicles (EVs) are small bilipid layer-enclosed vesicles that can be secreted by
all tested types of brain cells. Being a key intercellular communicator, EVs have emerged as …

Diseases of the central nervous system (CNS) are challenging to treat, mainly due to the
blood-brain barrier (BBB), which restricts drugs in circulation from entering target regions in …

Extracellular vesicles (EVs) derived from neural stem cells (NSC-EVs), astrocytes (ADEVs),
and microglia (MDEVs) have neuroregenerative properties. This review discusses the …

Cerebral ischemia, also known as ischemic stroke, accounts for nearly 85% of all strokes
and is the leading cause of disability worldwide. Due to disrupted blood supply to the brain …

Extracellular vesicles (EVs) have emerged as an attractive liquid biopsy approach in the
diagnosis and prognosis of multiple diseases and disorders. The feasibility of enriching …

Background Our previous studies have shown that berberine can improve the nerve function
deficits in ischemic stroke by inhibiting inflammation. The cellular communication between …

Extracellular vesicles (EVs) shed by neurons and glia in the central nervous system carry a
cargo of specific bioactive molecules, facilitating intercellular communication. However, in …

Background: aFGF content in serum and cerebrospinal fluid is increased in Alzheimer's
disease (AD) patients and attenuates the activation of astrocytes. Extracellular vesicles …